The outcome of trial off catheter after acute retention of urine

Annals of the Academy of Medicine Singapore

Volumn 28, Issue 4, 1999, Pages 516-518

  Lim, K B ^b   Wong, Michael Y C ^a   Foo, K T ^b  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b NONE

Author keywords

Acute retention of urine; Benign prostatic hypertrophy; Outcome

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ACUTE DISEASE; AGED; ARTICLE; BLOOD; CATHETERIZATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; STATISTICS; TIME; TRANSURETHRAL RESECTION; TREATMENT OUTCOME; URETHRA; URINE RETENTION;

ACUTE DISEASE; AGED; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; RISK FACTORS; TIME FACTORS; TRANSURETHRAL RESECTION OF PROSTATE; TREATMENT OUTCOME; URETHRA; URINARY CATHETERIZATION; URINARY RETENTION;

EID: 0033162020     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Taube M, Garaj M. Trial without catheter following acute retention of urine. Br J UroI 1989; 63:180-2.
2. Murray K, Massey A, Feneley RCL. Acute urinary retention - a urodynamic assessment. Br J Urol 1984; 56:468-73.
3. Jacobsen S J, Jacobsen D J, Girman C J, Roberts R O, Rhodes T, Guess H A, et al. Natural history of prostatism: risk factors for acute urinary retention. J Urol 1997; 158:481-7.
4. Powell P H, Smith PJ B, Feneley RCL. The identification of patients at risk from acute retention. Br J Urol 1980; 52:520-2.
5. Drach G W, Steinbronn D V. Clinical evaluation of patients with prostatic obstruction: correlation of flow rates with voided, residual or total bladder volume. J Urol 1986; 135:737-40.
6. Abrams P H, Griffiths D J. The assessment of prostatic obstruction from urodynamic measurements and from residual urine. Br J Urol 1979; 51:29-34.
7. Neal D E, Styles R A, Powell P H, Ramsden P D. Relationships between detrusor function and residual urine in men undergoing prostatectomy. Br J Urol 1987; 60:560-6.
8. Dunn M, Smith J C, Ardran G M. Prolonged bladder distension as a treatment of urgency and urge incontinence of urine. Br J Urol 1974; 46:645-52.
9. Nadler R B, Humphrey P A, Smith D S, Catalona W J, Ratliff T L. Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels. J Urol 1995; 154:407-13.
10. Collins G N, Lee R J, Mckelvie G B, Rogers A C N, Hehir M. Relationship between prostatic specific antigen, prostate volume and age in the benign prostate. Br J Urol 1993; 71:445-50.
11. Gleason P E, Jones J A, Regan J S, Salvas D B, Eble J N, Lamph W W, et al. Platelet derived growth factor, androgens and inflammation: possible etiologic factors in the development of prostatic hyperplasia. J Urol 1993; 149:1586-92.
12. Girman C J, Jacobsen S J, Guess H A, Oesterling J E, Chute C G, Panser L A, et al. Natural history of prostatism: relationship among symptoms, prostate volume and peak urinary flow rate. J Urol 1995; 153:1510-5.
13. Ezz El Din K, Kiemeney L A L M, De Wildt M J A M, Debruyne F M J, De La Rosette J J M C H. Correlation between uroflowmetry, prostate volume, postvoid residue and lower urinary tract symptoms as measured by the International Prostate Symptom Score. Urology 1996; 48:393-7.
14. Ezz El Din K, Koch W F R M, De Wildt M J A M, Kiemeney L A L M, Debruyne F M J, De La Rosette J J M C H. Reliability of the International Prostate Symptom Score in the assessment of patients with lower urinary tract symptoms and/or benign prostate hyperplasia. J Urol 1996; 155:1959-64.